Literature DB >> 9646157

Cardiac troponin I (cTn I) and the postmortem diagnosis of myocardial infarction.

E Osuna1, M D Pérez-Cárceles, M V Alvarez, J Noguera, A Luna.   

Abstract

In clinical practice several biochemical markers are used for the diagnosis of myocardial infarction. Because of its extremely high specificity for myocardial damage, cardiac troponin I (cTn I) is frequently used. The aim of this study was to evaluate the diagnostic efficacy of postmortem cTn I determinations in pericardial fluid and serum and to compare these results with other biochemical markers and with structural findings used to diagnose acute myocardial ischaemia. We studied 89 cadavers with a mean age of 51.38 +/- 2.04 (SD 19.27 years). Cases were allocated to 1 of 4 diagnostic groups depending on the probable intensity of myocardial damage and cause of death. In pericardial fluid we obtained statistically significant differences for the four biochemical parameters, while in serum myosin heavy chains and myoglobin showed statistically significant differences. The highest levels of biochemical markers in pericardial fluid were observed in subjects who had died from definite myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9646157     DOI: 10.1007/s004140050143

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  12 in total

Review 1.  Acp. Best practice no 155. Pathological investigation of deaths following surgery, anaesthesia, and medical procedures.

Authors:  R D Start; S S Cross
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

2.  Procalcitonin and C-reactive protein in pericardial fluid for postmortem diagnosis of sepsis.

Authors:  Bettina Schrag; Katia Iglesias; Patrice Mangin; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2012-03-29       Impact factor: 2.686

Review 3.  Postmortem chemistry update part II.

Authors:  Cristian Palmiere; Patrice Mangin
Journal:  Int J Legal Med       Date:  2011-10-09       Impact factor: 2.686

4.  Diagnostic role of postmortem CK-MB in cardiac death: a systematic review and meta-analysis.

Authors:  Chengyang Xu; Tianyi Zhang; Baoli Zhu; Zhipeng Cao
Journal:  Forensic Sci Med Pathol       Date:  2020-03-19       Impact factor: 2.007

5.  Postmortem serum nitrogen compounds and C-reactive protein levels with special regard to investigation of fatal hyperthermia.

Authors:  Hitoshi Maeda; Bao-Li Zhu; Yasumori Bessho; Takaki Ishikawa; Li Quan; Tomomi Michiue; Dong Zhao; Dong-Ri Li; Ayumi Komatsu
Journal:  Forensic Sci Med Pathol       Date:  2008-02-07       Impact factor: 2.007

6.  The impact of sex and myocardial ischemic preconditioning on immunohistochemical markers of acute myocardial infarction.

Authors:  K Scholl; R Huhn; St Ritz-Timme; F Mayer
Journal:  Int J Legal Med       Date:  2018-10-23       Impact factor: 2.686

7.  Can early myocardial infarction-related deaths be diagnosed using postmortem urotensin receptor expression levels?

Authors:  Mustafa Talip Sener; Emre Karakus; Zekai Halici; Erol Akpinar; Atilla Topcu; Ahmet Nezih Kok
Journal:  Forensic Sci Med Pathol       Date:  2014-06-18       Impact factor: 2.007

8.  Cardiac troponin T determination by a highly sensitive assay in postmortem serum and pericardial fluid.

Authors:  Lucas González-Herrera; Aurora Valenzuela; Valentín Ramos; Antonia Blázquez; Enrique Villanueva
Journal:  Forensic Sci Med Pathol       Date:  2016-03-08       Impact factor: 2.007

9.  Combined determination of B-type natriuretic peptide and high-sensitivity troponin I in the postmortem diagnosis of cardiac disease.

Authors:  Rafael Bañón; Diana Hernández-Romero; Esperanza Navarro; María Dolores Pérez-Cárceles; José Antonio Noguera-Velasco; Eduardo Osuna
Journal:  Forensic Sci Med Pathol       Date:  2019-08-30       Impact factor: 2.007

10.  Elevation of NT-proBNP and cardiac troponins in sepsis-related deaths: a forensic perspective.

Authors:  Camilla Tettamanti; Tania Hervet; Silke Grabherr; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2016-03-22       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.